SCHEDULE 13D

Company

Chemomab Therapeutics Ltd.

Filed

February 21, 2019

Accession Number

0001193125-19-047113

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →